News and Announcements
Syncona adds two oncology investments to portfolio
By Josh White
Date: Thursday 20 Jun 2024
(Sharecast News) - Life science investor Syncona announced the addition of two new oncology companies to its portfolio on Thursday.
The FTSE 250 company said the investments included leading an €80m (£68.4m) series-B financing round for iOnctura, and launching a new company, Yellowstone Biosciences, with a £16.5m series-A financing commitment.
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
Article Archive
You are here: news
